Recent Finacing
Recent Raise
Aduro BioTech is a clinical-stage immunotherapy company developing Listeria-based LADD vaccines, GVAX and synthetic STING-activating CDNs, advancing CRS-207 in pancreatic, mesothelioma and glioblastoma trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
